Home Contact us Sitemap

David Lee Robinson

Help us help a friend

Durham Regional Hospital

Progress

Target: £100,000

Raised so far: ~£67,000

Spread the word

 
Share |

An overwhelming response to an e-mail sent around the police forces throughout the UK has raised thousands! For more information on this incredible feat, please click here.

In a bid to raise awareness of our cause, we have created a poster which aims to inform people about us. Please feel free to download, print and display the poster. To download it please click here.

Events

We have organised some events in the name of our cause.

Three peaks - four of David's friends challenged themselves to climb three of Britain's highest peaks; Ben Nevis, Scafell Pike, and Snowdon all within 24 hours. For full details visit the Three Peaks event page.

8-10 May, 2010

186 mile bike ride - a sponsored and grueling bike ride from Leicester to Exeter covering around 186 miles of B roads in 24 hours, organised by Sergeant Nick White, David's colleague and friend.

1 May, 2010

Gig - a sell out ticket event attended by close to 300 people. This event has raised over £3,500 and has set the ball rolling.

5 March, 2010

We have more events in the planning stage. Visit the events section for more details.

Related Links

Hedgehog antagonist GDC-0449 is a medical trial at the Preston Robert Tisch Brain Tumour Centre, this is the trial for which we are raising money.

Help us help a friend is a Facebook group we've set up to gain more exposure. We welcome new members so please join and help spread the word.

Leicester Mercury, a local newspaper, has covered our bike ride event.

You're welcome to donate by postal cheque, however PayPal is generally more convenient. It is a quick, easy and secure donation process, completed with a few clicks and without sharing your financial information.
Donate by cheque, online banking or PayPal  |  How PayPal works

Medical Trial

This is what it all amounts to

Recurrent Medulloblastoma has long been considered universally fatal. In spite of attempts to improve its treatment, only rarely have long term survivors been documented in the world's medical literature. Although the treatment of primary Medulloblastoma is well established and includes surgical excision, postsurgical irradiation, and, more recently, chemotherapy, there is no established treatment for its recurrence. Current guidelines dictate the experimental use of chemotherapy, and there have been some encouraging results; yet no increase in long term survival has been documented.

The UK does not have many clinical trials into brain tumours and indeed, there is currently no clinical trial within the UK which is available to David. This is why David is hoping to enrol onto a clinical trial study at the Preston Robert Tisch Brain Tumour Centre at Duke Hospital in Durham, North Carolina, USA.

This particular trial is specifically aimed at adults with recurrent medulloblastoma so is suited to David's condition. This tumour is extremely rare yet extremely aggressive. The prognosis for patients, despite attempts to find a cure, have always looked bleak. This trial is a biological treatment using a new agent in the hope of slowing down the growth of these aggressive tumours and may be an effective treatment where others have been shown to fail.

Taking part in the trial would involve long periods away from home for David and Almina but as these aggressive tumours are fast growing and tend to spread, they can only attempt to try something new in the hope of extending David's life as the chemotherapy treatment so far has not proven to slow down the growth and symptoms of these tumours. There are only few remaining options left and this trial is one.

David and Almina do not have the means to be able to afford this treatment and are relying on your kindness and generosity to help them get there in the hope that they can enjoy a longer future together with each other and the daughter who is due to the young couple in May this year.

Please feel free to browse the link to further details of this particular trial.

http://www.clinicaltrial.gov/ct2/show/NCT00939484